Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 811 of 6351
-
Can a diet and coaching program reverse type 2 diabetes in memphis?
Disease control CompletedThe HEAL Diabetes Program is a multicomponent intensive plant-forward healthy eating program designed to reverse diabetes. Several recent studies, most notably the Diabetes UK-funded Diabetes Remission Clinical Trial (DiRECT) in England and Scotland, have demonstrated that intens…
Sponsor: University of Tennessee • Aim: Disease control
Last updated Jun 27, 2026 08:08 UTC
-
Can a new laser erase acne scars without harming darker skin?
Symptom relief Recruiting nowThe investigators aim to investigate the efficacy and tolerability of a hybrid non-ablative/ablative laser for acne scarring in skin of color.
Sponsor: Montefiore Medical Center • Aim: Symptom relief
Last updated Aug 13, 2026 00:00 UTC
-
Antioxidant pill shows promise in slowing blindness
Disease control OngoingRetinitis pigmentosa (RP) is an inherited retinal degeneration caused by one of several mistakes in the genetic code. Such mistakes are called mutations. The mutations cause degeneration of rod photoreceptors which are responsible for vision in dim illumination resulting in night…
Phase 3 • Sponsor: Johns Hopkins University • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
Can a simple blood thinner keep pneumonia patients out of the ICU?
Disease control Recruiting nowThis is an international, open-label, stratified randomized controlled trial with Bayesian adaptive stopping rules to compare the effects of therapeutic-dose heparin vs. usual care pharmacological thromboprophylaxis on outcomes in patients admitted to hospital with community acqu…
Phase 3 • Sponsor: University of Manitoba • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC
-
New combo therapy for advanced lung cancer tested in Real-World study
Disease control Recruiting nowThis single-arm, multi-center study is to evaluate Sugemalimab plus platinum-based chemotherapy as first-line therapy for patients with locally advanced and metastatic NSCLC in a real-world setting.
Sponsor: Peking Union Medical College • Aim: Disease control
Last updated Jun 27, 2026 07:59 UTC
-
New hope for lung transplant patients: drug may slow chronic rejection
Disease control Recruiting nowThis double-blind, randomized, placebo-controlled, multinational, multicenter, parallel-group, Phase 3, 2-arm, study will investigate the efficacy and safety of belumosudil compared with placebo, both administered on top of azithromycin and standard-of-care regimen of immunosuppr…
Phase 3 • Sponsor: Sanofi • Aim: Disease control
Last updated Jul 01, 2026 00:00 UTC
-
New heart preservation method could expand donor pool for transplants
Disease control OngoingThe purpose of this study is to evaluate if Non-Ischemic Heart Preservation (NIHP) of extended criteria donor hearts using the XVIVO Heart Preservation System (XHPS) is a safe and effective way to preserve and transport hearts for transplantation.
Sponsor: XVIVO Perfusion • Aim: Disease control
Last updated Aug 19, 2026 00:00 UTC
-
Engineered donor cells take aim at tough blood cancers in early trial
Disease control PausedEffective treatment options for relapsed/refractory acute myeloid leukemia (AML) and T-cell non-Hodgkin lymphoma (T-NHL) represent a significant unmet medical need. CAR T therapy has offered durable remissions and potential cures in some forms of hematologic malignancy, including…
Phase 1 • Sponsor: Washington University School of Medicine • Aim: Disease control
Last updated Jul 23, 2026 00:00 UTC
-
Could a gentler ICU environment boost brain development in heart babies?
Disease control OngoingThe proposed study includes a newborn developmental intervention to improve neurodevelopmental (ND) and medical outcomes for infants with congenital heart disease (CHD) with improved parent well-being. Literature documents long-term ND disabilities for children with CHD, caused b…
Sponsor: Boston Children's Hospital • Aim: Disease control
Last updated Jul 03, 2026 00:00 UTC
-
Virtual reality could transform uncomfortable bladder exams
Symptom relief CompletedThe aim of this research is to conduct a two-group randomized controlled intervention study to determine the effect of virtual reality applications on pain and anxiety during cystoscopy. The study population will consist of patients who have applied to the urology outpatient clin…
Sponsor: Cukurova University • Aim: Symptom relief
Last updated Aug 06, 2026 00:00 UTC
-
New device aims to clear stroke clots faster and safer
Disease control CompletedThe objectives of the study are to examine the performance and safety characteristics of the Millipede System when used for revascularization of patients with acute ischemic stroke due to Large Vessel Occlusions (LVOs) and to record associated clinical outcomes.
Sponsor: Perfuze • Aim: Disease control
Last updated Jul 12, 2026 00:00 UTC
-
Tapping away trauma: can EFT heal childbirth distress?
Symptom relief CompletedThis randomized controlled trial evaluated the effect of Emotional Freedom Technique (EFT) on perceived traumatic childbirth, anxiety, and psychological well-being among women with perceived traumatic childbirth. Eligible women were randomly assigned to either the EFT group or th…
Sponsor: Ümmügülsüm Ulutaş • Aim: Symptom relief
Last updated Aug 21, 2026 00:00 UTC
-
New pill could tame ulcerative colitis Flare-Ups
Disease control CompletedThe purpose of this study is to evaluate the safety and effectiveness of JNJ-77242113 compared with placebo in participants with moderately to severely active ulcerative colitis.
Phase 2 • Sponsor: Janssen Research & Development, LLC • Aim: Disease control
Last updated Jun 27, 2026 12:06 UTC
-
Scientists aim to forecast migraine pain using wearable sensors and early symptoms
Knowledge-focused Recruiting nowThe study of the ability to predict pain in a migraine attack, through premonitory symptoms and through an ambulatory monitoring device through real-time recording of hemodynamic variables, is one of the strategic lines of research of the unit. of Headaches at the Hospital de La …
Sponsor: Fundación de Investigación Biomédica - Hospital Universitario de La Princesa • Aim: Knowledge-focused
Last updated Jul 04, 2026 00:00 UTC
-
The eyes as a window to the brain: can a simple scan monitor MS, Alzheimer's, and Parkinson's?
Knowledge-focused Recruiting nowOCt.IN.N is a national, monocentric, prospective, observational cohort study evaluating the utility and applicability of Optical Coherence Tomography (OCT) in the diagnostic workup and longitudinal monitoring of neurological diseases. 840 patients with Central Nervous System neu…
Sponsor: IRCCS San Raffaele • Aim: Knowledge-focused
Last updated Jul 24, 2026 00:00 UTC
-
New drug combo shows promise for tough breast cancer
Disease control CompletedThis is an international, multisite, open-label, Phase 1b/2 study, to confirm safety and efficacy of samuraciclib in combination with elacestrant in adult participants with metastatic or locally advanced Hormone Receptor (HR) positive and Human Epidermal Growth Factor Receptor (H…
Phase 1/2 • Sponsor: Carrick Therapeutics Limited • Aim: Disease control
Last updated Jun 27, 2026 12:00 UTC
-
Can saving the meniscus save knees from osteoarthritis?
Disease control Recruiting nowThe menisci of the knee joint are structures composed of cartilage and connective tissue, whose primary functions are to stabilize the joint and distribute weight across joint surfaces. In doing so, it helps protect the joint from osteoarthritis - a form of joint failure commonly…
Sponsor: Region Skane • Aim: Disease control
Last updated Aug 15, 2026 00:00 UTC
-
New chemo cocktail aims to stop triple negative breast cancer from returning
Disease control OngoingThis clinical trial aims to evaluate the efficacy, safety, and exploratory measures of liposomal doxorubicin and carboplatin combination therapy in the adjuvant setting for early stage triple negative breast cancer (TNBC) patients. The primary objective is to determine the effec…
Phase 2 • Sponsor: Mridula George, MD • Aim: Disease control
Last updated Jun 27, 2026 07:57 UTC
-
New trial: can targeted radiation boost survival in patients with up to 10 metastases?
Disease control Recruiting nowThis study is a phase III multi-institutional randomized trial. Patients will be randomized in a 1:2 ratio between current standard of care treatment (Arm 1) vs. standard of care treatment + SABR (Arm 2) to sites of known disease. Patients will be stratified by two of the strong…
Phase 3 • Sponsor: David Palma • Aim: Disease control
Last updated Jun 27, 2026 08:07 UTC
-
MDMA therapy shows promise for Veterans' PTSD and relationships
Symptom relief CompletedThe goal of this pilot trial is to examine the preliminary effectiveness of MDMA-facilitated bCBCT for improving chronic PTSD and relationship functioning in a sample of veterans and their intimate partners seeking care within the VA San Diego Healthcare System.
Phase 3 • Sponsor: Dr. Leslie Morland • Aim: Symptom relief
Last updated Jun 27, 2026 08:02 UTC